Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;42(1):303-9.
doi: 10.1590/S1517-83822011000100039.

Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients

Wafaa M El-Emshaty  1 , Douaa Raafat, Doaa M Elghannam, Niveen Saudy, Ehab E Eltoraby, Abd Elhameed A Metwalli
Affiliations

Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients

Wafaa M El-Emshaty et al. Braz J Microbiol. 2011 Jan.

Abstract

Nosocomial transmission of HCV is a concern in haemodialysis (HD) units worldwide. Diagnosis of HCV infection among dialysis patients is currently based on the detection of anti HCV antibodies by ELISA, and is confirmed by HCV RNA. The average window period between HCV infection and seroconversion with new generations of HCV antibody tests remains approximately 70 days with more prolonged period among dialysis patients. In this study we assessed the diagnostic performance of an immunoassay designed for simultaneous detection of anti HCV antibodies and core antigen in one step in comparison to qualitative RT-PCR and anti HCV antibodies detection test among Egyptian haemodialysis patients. The studied patients were 39 chronic renal failure patients on maintenance haemodialysis. The results obtained in the present study revealed HCV infection of 56.4%. Combined Ag/Ab test detected 3 out of the 4 anti-HCV negative viraemic patients who were in the window period. The sensitivity, specificity and accuracy of the test were higher than that of anti HCV antibodies detection test (95.45%, 94.1% and 94.87% versus 81.8%, 88.23% and 84.6%) and they were raised to 100% on combining its positivity with liver enzymes elevation results. Therefore, this simple combined Ag/Ab test can be applied for early detection of HCV infection during window period among HD patients as an alternative to HCV RNA detection.

Keywords: Egypt; HCV; HCV core antigen; haemodialysis; immunoassay.

PubMed Disclaimer

References

    1. Alados-Arboledas, J.C.; Calbo-Torrecillas, L.; López-Prieto, M.D.; de Francisco-Ramírez, J.L.; de Miguel-Sastre, C. (2007) Clinical assessment of Monolisa HCV Ag-Ab ULTRA (Bio-Rad) in a general hospital. Enferm Infecc Microbiol Clin 25(3):172–176. - PubMed
    1. Alavian, S.M. (2009). A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol 14; 15(6):641–646. - PMC - PubMed
    1. Alzahrani, A.J. (2008). Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. J Med Virol 80(4):603–606 - PubMed
    1. Aoyagi, K.; Ohue, C.; Iida, K.; Kimura, T.; Tanaka, E.; Kiyosawa, K.; Yagi, S. (1999). Development of a simple and highly sensitive enzyme immunoassay for HCV core antigen. J. Clin. Microbiol, 37, 1802–1808. - PMC - PubMed
    1. Barrera, J.M.; Francis, B.; Ercilla, G.; Nelles, M.; Achord, D.; Darner, J.; Lee, S.R. (1995). Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang, 68, 15–18. - PubMed

LinkOut - more resources